SCC289
SF295 Human Glioblastoma Cell Line
SF295 human glioblastoma cell line is a valuable model for glioblastoma research.
About This Item
Recommended Products
application(s)
cell analysis
General description
SF295 is a patient-derived glioblastoma cell line originating from a temporal lobe tumor (2). SF295 cells do not express the glial markers GFAP or glutamine synthetase, but have been shown to positively express neurofibromin-1, identified as one of the most frequently mutated factors in glioblastoma multiforme (3). SF295 cells exhibit hypertriploidy and glial-like morphology in culture and are non-tumorigenic in athymic mice (2). The SF295 cell line is highly published in studies of chemotherapeutic treatments for glioblastoma, representing a valuable cellular model for assessment of drugs and molecular modulators for their effect on glioblastomas.
<bold>Source:</bold>
The SF295 glioblastoma cell line was derived from the left frontal lobe tumor of a 67-year-old female patient (2).
Research Category:
Cancer
Cell Line Origin
Packaging
Storage and Stability
Other Notes
Disclaimer
Storage Class Code
10 - Combustible liquids
WGK
WGK 1
Flash Point(F)
212.0 °F
Flash Point(C)
100 °C
Regulatory Listings
Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.
JAN Code
SCC289:
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service